Guaifenesin
- Product NDC
- 81033-102
- 11-digit product format
- 810330102
- Labeler code
- 81033
- Product ID
- 81033-102_316ac9e6-8d03-f55a-e063-6294a90a8540
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- KESIN PHARMA CORPORATION
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-11-20
- Substance
- GUAIFENESIN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310604 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 365c01b7-a197-4876-85fc-42204f787e3a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-102-05 | Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 7 | |
| 81033-102-10 | Guaifenesin | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 7 | |
| 81033-102-51 | Guaifenesin | 50 in 1 CARTON | LIQUID | 50 | 7 | |
| 81033-102-52 | Guaifenesin | 50 in 1 CARTON | LIQUID | 50 | 7 | |
| 81033-102-16 | Guaifenesin | 473 mL in 1 BOTTLE | LIQUID | 473 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-102-05 | ML - Milliliter | 81033-102 | c04493a2-a5df-4be5-86e1-38cd698bbd63 | 1 | 2024-03-12 |
| 81033-102-10 | ML - Milliliter | 81033-102 | a990cc84-2678-4699-8dca-ec8808a024a4 | 1 | 2024-04-05 |
| 81033-102-16 | ML - Milliliter | 81033-102 | 7a1f8916-cb71-4e4c-a447-b4f532f27ea3 | 1 | 2025-06-13 |
| 81033-102-51 | ML - Milliliter | 81033-102 | 118824ef-231f-4404-85a9-9e31242703de | 1 | 2024-01-04 |
| 81033-102-52 | ML - Milliliter | 81033-102 | 0be6c67c-993a-4d6d-9ecc-515e876c5d39 | 1 | 2024-01-04 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 81033-102 | GUAIFENESIN LIQUID [KESIN PHARMA CORPORATION] | 7 | Current NDC, 4 package rows | 20250331_365c01b7-a197-4876-85fc-42204f787e3a.zip |
| 81033-102 | GUAIFENESIN LIQUID [KESIN PHARMA CORPORATION] | 1 | Current NDC, 1 package rows | 20250406_31b8ad0a-3637-03db-e063-6394a90acdc3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Day Cold and Flu and Night Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, TRIPROLIDINE HCL | TARGET CORPORATION | 08ee56d1-b11d-3e36-e063-6294a90acd5f | 2024-08-22 | Warnings | M012 |
| Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE,TRIPROLIDINE HYDROCHLORIDE | TARGET CORPORATION | 0fc523ce-55a7-6384-e063-6394a90aad3f | 2024-08-22 | Warnings | M012 |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Walgreens | 8045aef9-22bc-4146-b494-dbb1ffef06df | 2024-08-19 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 5a2053d4-9c0d-4613-9cf5-0067173f3730 | 2024-08-16 | Warnings | M012 |
| QUALITY CHOICE Long Acting Cough Softgel | DEXTROMETHORPHAN HYDROBROMIDE | Chain Drug Marketing Association, Inc. | f1ea7dfc-c605-45a1-ad1d-6e636a8a7b1c | 2024-08-16 | Warnings | M012 |
| pseudoephedrine hydrochloride | PSEUDOEPHEDRINE HCL | Padagis Israel Pharmaceuticals Ltd | 458594e1-8d99-4de3-8923-2fd8ce2fc406 | 2024-08-16 | Warnings | M012 |
| Halls Sugar Free Mountain Menthol | MENTHOL | Mondelez Global LLC | 54e0d57e-1f48-45e2-86b3-0e50775996f4 | 2024-08-15 | Warnings | M012 |
| SanaTos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | 1fc1408c-c540-39ab-e063-6394a90aa477 | 2024-08-15 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals, Inc. | 489645ad-d7da-5f52-e054-00144ff8d46c | 2024-08-14 | Warnings | M012 |
| nasal | OXYMETAZOLINE HYDROCHLORIDE | Rite Aid Corporation | 6c949602-e0c8-40ce-8fb3-5147f406fa04 | 2024-08-14 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals, Inc. | 3dbdf020-ca17-1197-e054-00144ff8d46c | 2024-08-13 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 445e49a2-6ed0-434c-aaea-3ce14bc7df59 | 2024-08-12 | Warnings | M012 |
| Allergy Multi Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | d49b42ad-0ae0-48c9-adba-5fc2ced97764 | 2024-08-12 | Warnings | M012 |
| RYMED | DEXCHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE | EDWARDS PHARMACEUTICALS, INC. | c1d6e914-74cc-4cdf-9587-7eaaa4a386e5 | 2024-08-12 | Warnings | M012 |
| WesTussin DM NF | WESTUSSIN DM NF | Westminster Pharmaceuticals, LLC | 4e0f9f97-a31c-41ac-9d6c-d81efd20fcef | 2024-08-08 | Warnings | M012 |
| Mucus Relief Sinus Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 2f2a2864-af11-4240-bdad-a54aca58d01b | 2024-08-07 | Warnings | M012 |
| Cold plus Flu Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 0199aea2-a9c1-4c9d-8786-28b9dadc832e | 2024-08-07 | Warnings | M012 |
| Mucus Relief Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 32d1ce6e-2617-4b50-a9e6-2e1941465dff | 2024-08-07 | Warnings | M012 |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 07362db5-a372-4463-af8b-06e8783ca865 | 2024-08-07 | Warnings | M012 |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1fb11d90-48bf-4baa-9b3a-5d64d81e3a06 | 2024-08-07 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 365c01b7-a197-4876-85fc-42204f787e3a | 7 |
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 81033-102-05 | 81033010205 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | |||
| 81033-102-10 | 81033010210 | 10 mL in 1 CUP, UNIT-DOSE | 10 ml | Historical | |||
| 81033-102-16 | 81033010216 | 473 mL in 1 BOTTLE (81033-102-16) | 473 ml | 2025-04-01 | No | No | Current |
| 81033-102-51 | 81033010251 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-51) / 5 mL in 1 CUP, UNIT-DOSE (81033-102-05) | 2023-11-20 | No | No | Current | |
| 81033-102-52 | 81033010252 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-102-10) | 2023-11-20 | No | No | Current |